173 related articles for article (PubMed ID: 37156797)
21. Metastatic Brain Tumors Disrupt the Blood-Brain Barrier and Alter Lipid Metabolism by Inhibiting Expression of the Endothelial Cell Fatty Acid Transporter Mfsd2a.
Tiwary S; Morales JE; Kwiatkowski SC; Lang FF; Rao G; McCarty JH
Sci Rep; 2018 May; 8(1):8267. PubMed ID: 29844613
[TBL] [Abstract][Full Text] [Related]
22. Zika virus degrades the ω-3 fatty acid transporter Mfsd2a in brain microvascular endothelial cells and impairs lipid homeostasis.
Zhou J; Chi X; Cheng M; Huang X; Liu X; Fan J; Xu H; Lin T; Shi L; Qin C; Yang W
Sci Adv; 2019 Oct; 5(10):eaax7142. PubMed ID: 31681849
[TBL] [Abstract][Full Text] [Related]
23. Aging decreases docosahexaenoic acid transport across the blood-brain barrier in C57BL/6J mice.
Iwao T; Takata F; Matsumoto J; Aridome H; Yasunaga M; Yokoya M; Kataoka Y; Dohgu S
PLoS One; 2023; 18(2):e0281946. PubMed ID: 36795730
[TBL] [Abstract][Full Text] [Related]
24. Mfsd2a-based pharmacological strategies for drug delivery across the blood-brain barrier.
Wang JZ; Xiao N; Zhang YZ; Zhao CX; Guo XH; Lu LM
Pharmacol Res; 2016 Feb; 104():124-31. PubMed ID: 26747400
[TBL] [Abstract][Full Text] [Related]
25. A partially inactivating mutation in the sodium-dependent lysophosphatidylcholine transporter MFSD2A causes a non-lethal microcephaly syndrome.
Alakbarzade V; Hameed A; Quek DQ; Chioza BA; Baple EL; Cazenave-Gassiot A; Nguyen LN; Wenk MR; Ahmad AQ; Sreekantan-Nair A; Weedon MN; Rich P; Patton MA; Warner TT; Silver DL; Crosby AH
Nat Genet; 2015 Jul; 47(7):814-7. PubMed ID: 26005865
[TBL] [Abstract][Full Text] [Related]
26. Unveiling the role of Mfsd2a and LPC-DHA in kidney repair.
Rietjens RGJ; Rabelink TJ
J Lipid Res; 2023 Sep; 64(9):100422. PubMed ID: 37549789
[No Abstract] [Full Text] [Related]
27. Structured form of DHA prevents neurodegenerative disorders: A better insight into the pathophysiology and the mechanism of DHA transport to the brain.
Balakrishnan J; Kannan S; Govindasamy A
Nutr Res; 2021 Jan; 85():119-134. PubMed ID: 33482601
[TBL] [Abstract][Full Text] [Related]
28. Mfsd2a Attenuates Blood-Brain Barrier Disruption After Sub-arachnoid Hemorrhage by Inhibiting Caveolae-Mediated Transcellular Transport in Rats.
Zhao C; Ma J; Wang Z; Li H; Shen H; Li X; Chen G
Transl Stroke Res; 2020 Oct; 11(5):1012-1027. PubMed ID: 31907728
[TBL] [Abstract][Full Text] [Related]
29. Perspective: The Potential Role of Circulating Lysophosphatidylcholine in Neuroprotection against Alzheimer Disease.
Semba RD
Adv Nutr; 2020 Jul; 11(4):760-772. PubMed ID: 32190891
[TBL] [Abstract][Full Text] [Related]
30. Blood-brain barrier: a dual life of MFSD2A?
Zhao Z; Zlokovic BV
Neuron; 2014 May; 82(4):728-30. PubMed ID: 24853933
[TBL] [Abstract][Full Text] [Related]
31. MFSD2A Promotes Endothelial Generation of Inflammation-Resolving Lipid Mediators and Reduces Colitis in Mice.
Ungaro F; Tacconi C; Massimino L; Corsetto PA; Correale C; Fonteyne P; Piontini A; Garzarelli V; Calcaterra F; Della Bella S; Spinelli A; Carvello M; Rizzo AM; Vetrano S; Petti L; Fiorino G; Furfaro F; Mavilio D; Maddipati KR; Malesci A; Peyrin-Biroulet L; D'Alessio S; Danese S
Gastroenterology; 2017 Nov; 153(5):1363-1377.e6. PubMed ID: 28827082
[TBL] [Abstract][Full Text] [Related]
32. Efficient Enrichment of Retinal DHA with Dietary Lysophosphatidylcholine-DHA: Potential Application for Retinopathies.
Sugasini D; Yalagala PCR; Subbaiah PV
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33053841
[TBL] [Abstract][Full Text] [Related]
33. Plasma BDNF is a more reliable biomarker than erythrocyte omega-3 index for the omega-3 fatty acid enrichment of brain.
Sugasini D; Yalagala PCR; Subbaiah PV
Sci Rep; 2020 Jul; 10(1):10809. PubMed ID: 32616795
[TBL] [Abstract][Full Text] [Related]
34. The Role of Major Facilitator Superfamily Domain-Containing 2a in the Central Nervous System.
He Z; Zhao Y; Sun J
Cell Mol Neurobiol; 2023 Mar; 43(2):639-647. PubMed ID: 35438385
[TBL] [Abstract][Full Text] [Related]
35. Child Head Circumference and Placental MFSD2a Expression Are Associated to the Level of MFSD2a in Maternal Blood During Pregnancy.
Sánchez-Campillo M; Ruiz-Palacios M; Ruiz-Alcaraz AJ; Prieto-Sánchez MT; Blanco-Carnero JE; Zornoza M; Ruiz-Pastor MJ; Demmelmair H; Sánchez-Solís M; Koletzko B; Larqué E
Front Endocrinol (Lausanne); 2020; 11():38. PubMed ID: 32117064
[TBL] [Abstract][Full Text] [Related]
36. Placental MFSD2a transporter is related to decreased DHA in cord blood of women with treated gestational diabetes.
Prieto-Sánchez MT; Ruiz-Palacios M; Blanco-Carnero JE; Pagan A; Hellmuth C; Uhl O; Peissner W; Ruiz-Alcaraz AJ; Parrilla JJ; Koletzko B; Larqué E
Clin Nutr; 2017 Apr; 36(2):513-521. PubMed ID: 26869380
[TBL] [Abstract][Full Text] [Related]
37. Hypertension depresses but exercise training restores both Mfsd2a expression and blood-brain barrier function within PVN capillaries.
Perego SM; Raquel HA; Candido VB; Masson GS; Martins MM; Ceroni A; Michelini LC
Am J Physiol Regul Integr Comp Physiol; 2023 Sep; 325(3):R299-R307. PubMed ID: 37458379
[TBL] [Abstract][Full Text] [Related]
38. Comparative Analyses of EPA-Phosphatidylcholine, EPA-Lysophosphatidylcholine, and DHA-Lysophosphatidylcholine on DHA and EPA Repletion in n-3 PUFA-Deficient Mice.
Cui XY; Jiang S; Wang CC; Yang JY; Zhao YC; Xue CH; Wang YM; Zhang TT
J Agric Food Chem; 2022 Oct; 70(41):13327-13339. PubMed ID: 36197792
[TBL] [Abstract][Full Text] [Related]
39. Insights into major facilitator superfamily domain-containing protein-2a (Mfsd2a) in physiology and pathophysiology. What do we know so far?
Eser Ocak P; Ocak U; Sherchan P; Zhang JH; Tang J
J Neurosci Res; 2020 Jan; 98(1):29-41. PubMed ID: 30345547
[TBL] [Abstract][Full Text] [Related]
40. Fatty Acid-Binding Protein 5 Facilitates the Blood-Brain Barrier Transport of Docosahexaenoic Acid.
Pan Y; Scanlon MJ; Owada Y; Yamamoto Y; Porter CJ; Nicolazzo JA
Mol Pharm; 2015 Dec; 12(12):4375-85. PubMed ID: 26455443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
